Cigna Investments’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $200K | Sell |
716
-77
| -10% | -$20.2K | 0.03% | 469 |
|
|
2026
Q1 | $212K | Sell |
793
-29
| -4% | -$7.85K | 0.03% | 429 |
|
|
2025
Q4 | $206K | Hold |
822
| – | – | 0.03% | 440 |
|
|
2025
Q3 | $236K | Hold |
822
| – | – | 0.03% | 410 |
|
|
2025
Q2 | $216K | Buy |
+822
| New | +$200K | 0.04% | 426 |
|
|
2024
Q1 | – | Sell |
-916
| Closed | -$208K | – | 463 |
|
|
2023
Q4 | $208K | Buy |
+916
| New | +$192K | 0.04% | 416 |
|
|
2023
Q3 | – | Sell |
-1,247
| Closed | -$258K | – | 443 |
|
|
2023
Q2 | $258K | Hold |
1,247
| – | – | 0.05% | 377 |
|
|
2023
Q1 | $246K | Sell |
1,247
-28
| -2% | -$5.76K | 0.05% | 383 |
|
|
2022
Q4 | $258K | Sell |
1,275
-18
| -1% | -$3.52K | 0.05% | 368 |
|
|
2022
Q3 | $228K | Sell |
1,293
-85
| -6% | -$17.4K | 0.05% | 382 |
|
|
2022
Q2 | $278K | Sell |
1,378
-533
| -28% | -$114K | 0.06% | 350 |
|
|
2022
Q1 | $434K | Sell |
1,911
-680
| -26% | -$160K | 0.05% | 339 |
|
|
2021
Q4 | $700K | Sell |
2,591
-885
| -25% | -$219K | 0.05% | 296 |
|
|
2021
Q3 | $840K | Sell |
3,476
-201
| -5% | -$50.7K | 0.06% | 288 |
|
|
2021
Q2 | $872K | Sell |
3,677
-476
| -11% | -$108K | 0.06% | 284 |
|
|
2021
Q1 | $910K | Buy |
4,153
+142
| +4% | +$28.5K | 0.06% | 290 |
|
|
2020
Q4 | $702K | Buy |
4,011
+283
| +8% | +$48.9K | 0.05% | 313 |
|
|
2020
Q3 | $603K | Hold |
3,728
| – | – | 0.06% | 299 |
|
|
2020
Q2 | $532K | Buy |
3,728
+461
| +14% | +$63.8K | 0.05% | 366 |
|
|
2020
Q1 | $355K | Buy |
3,267
+174
| +6% | +$25.1K | 0.05% | 403 |
|
|
2019
Q4 | $465K | Sell |
3,093
-322
| -9% | -$46.5K | 0.05% | 406 |
|
|
2019
Q3 | $484K | Buy |
3,415
+174
| +5% | +$25.4K | 0.05% | 402 |
|
|
2019
Q2 | $467K | Sell |
3,241
-232
| -7% | -$32.4K | 0.05% | 406 |
|
|
2019
Q1 | $456K | Hold |
3,473
| – | – | 0.05% | 408 |
|
|
2018
Q4 | $376K | Sell |
3,473
-85
| -2% | -$11.4K | 0.03% | 427 |
|
|
2018
Q3 | $490K | Sell |
3,558
-350
| -9% | -$53.2K | 0.04% | 366 |
|
|
2018
Q2 | $602K | Sell |
3,908
-483
| -11% | -$72.9K | 0.04% | 364 |
|
|
2018
Q1 | $610K | Sell |
4,391
-116
| -3% | -$17K | 0.04% | 384 |
|
|
2017
Q4 | $619K | Sell |
4,507
-164
| -4% | -$21.7K | 0.04% | 386 |
|
|
2017
Q3 | $606K | Sell |
4,671
-27
| -0.6% | -$3.6K | 0.04% | 382 |
|
|
2017
Q2 | $622K | Sell |
4,698
-254
| -5% | -$31.1K | 0.04% | 373 |
|
|
2017
Q1 | $610K | Buy |
4,952
+457
| +10% | +$54.1K | 0.04% | 384 |
|
|
2016
Q4 | $496K | Buy |
+4,495
| New | +$499K | 0.05% | 403 |
|
Other funds holding LH
RRAM
JIC
BCWM
AAM
DIA
SFA
WCM
HPCM
MCM
ET
Cigna Investments's LH Position: Q2 2026 in Review
Cigna Investments reduced its Labcorp (LH) stake by 9.7% in Q2 2026, selling an estimated $20.2K and leaving 716 shares worth $200K. The position accounts for 0.03% of the portfolio, ranked #469.
Cigna Investments first reported a position in LH in Q4 2016 and has held it in 33 quarters since. The position peaked at $910K in Q1 2021. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Cigna Investments held 716 shares of Labcorp worth $200K as of Q2 2026.
- Cigna Investments sold 77 Labcorp shares in Q2 2026, an estimated $20.2K.
- Labcorp made up 0.03% of Cigna Investments's portfolio in Q2 2026, its #469 holding.
- Cigna Investments first reported a position in Labcorp in Q4 2016 and has held it in 33 quarters since.
- Cigna Investments's Labcorp position peaked at $910K in Q1 2021.
- 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.